Amazon.com Inc vs Becton Dickinson and Co — how do they compare? Amazon.com Inc trades at $268.16 (market cap $2.94T), while Becton Dickinson and Co trades at $180.3 (market cap $49.41B). The key difference: Amazon.com Inc is far larger — about 59.5× Becton Dickinson and Co's market cap, and Becton Dickinson and Co pays a 2.32% dividend while Amazon.com Inc pays none. Which is the better fit depends on your goals.
| AMZN | BDX | |
|---|---|---|
Market Cap | $2.94T | $49.41B |
Volume | 3,931,282 | — |
Sector | Consumer Cyclical | Health |
52-Week High | $284.02 | $185.39 |
52-Week Low | $198.79 | $138.62 |
Enterprise Value | $3.04T | $65.51B |
Dividend Yield | — | 2.32% |
Signals from Pluang's Aura AI — not financial advice
Amazon (AMZN) trades at $278.09, up 1.32% with strong bullish momentum as technical indicators show the stock above key support levels. The company demonstrates robust fundamentals with revenue growing to $716.92 billion in 2025 and net income reaching $77.67 billion, representing a 10.83% margin. Recent earnings beats in Q1 and Q2 2026 exceeded expectations significantly, while analyst sentiment remains overwhelmingly positive with 89% buy ratings.
Amazon's outlook remains favorable with continued revenue growth projected to $775.7 billion in 2026 and expanding profit margins. The primary investment opportunity lies in AWS growth and AI chip development, though risks include intense competition in e-commerce and significant capital expenditures. With a consensus price target of $333.86 representing 20% upside potential, the stock appears positioned for continued growth despite near-term overbought technical conditions.
BDX trades at $179.63, up 1.57% with a bullish technical outlook supported by moving averages. The company reported strong Q3 2026 earnings, beating estimates with $3.23 EPS versus $3.14 expected, and raised full-year guidance. Revenue growth remains steady at 4.4% FX-neutral, though margins face pressure from tariffs. Analysts maintain a mixed consensus with 47% buy ratings and a $183 price target, suggesting modest upside from current levels.
The stock presents a balanced opportunity with solid fundamentals and dividend stability, but faces headwinds from margin compression and competitive pressures. Near-term catalysts include continued execution on growth initiatives, while risks include tariff impacts and healthcare regulatory changes. The current valuation at 31.39 P/E appears fair given growth prospects.
Trailing returns across standard periods
Latest headlines on both assets
Amazon.com, Inc. is an online retailer that offers a wide range of products. The Company products include books, music, computers, electronics and numerous other products. Amazon offers personalized shopping services, Web-based credit card payment, and direct shipping to customers. Amazon also operates a cloud platform offering services globally.
Read more on AMZN →Becton, Dickinson is the world's largest manufacturer and distributor of medical surgical products, such as needles, syringes, and sharps-disposal units. The company also manufactures diagnostic instruments and reagents, as well as flow cytometry and cell-imaging systems. BD Interventional (largely the former Bard business) accounts for 23% of revenue. International revenue accounts for 44% of the company's business.
Read more on BDX →